Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Sinch AB (publ): Interim Report, January – September 2020

Interim Report, January – September 2020 July – September 2020 · Net sales increased by 46 percent to SEK 1,777.7 million (1,216.4). Organic growth was 35 percent. · Gross profit increased by 40 percent to SEK 480.6 million (343.6). Organic growth was 24 percent. · Adjusted EBITDA1 increased by 53 percent to SEK 226.0 million (147.6). · Adjusted EBIT2 amounted to SEK 210.7 million (131.5). · Profit after tax for the quarter amounted to SEK 96.4 million (68.7). · Diluted earnings per share were SEK 1.56 (1.27). January – September 2020 · Net sales increased by

AcuCort is granted a patent in China for the drug ISICORT®

AcuCort AB (Spotlight Stock Market: ACUC) today announced that the China National Intellectual Property Administration has granted the company’s patent application for its drug ISICORT®. The company has an active patent strategy covering all major geographic markets, including China.ISICORT® is a thin, fast-dissolving and user-friendly oral film for the treatment of acute and severe allergic reactions, for croup in children and chemotherapy-induced nausea and vomiting (CINV). The fast-dissolving oral film contains the glucocorticoid dexamethasone which is a well-known, often used and well-

The importance of good neighbours in catalysis

Are you affected by your neighbours? So are nanoparticles in catalysts. New research from Chalmers University of Technology, Sweden, published in the journals Science Advances and Nature Communications, reveals how the nearest neighbours determine how well nanoparticles work in a catalyst. “The long-term goal of the research is to be able to identify ‘super-particles’, to contribute to more efficient catalysts in the future. To utilise the resources better than today, we also want as many particles as possible to be actively participating in the catalytic reaction at the same

Observe Medical ASA: Interim report third quarter 2020

Oslo, November 3rd, 2020 - Observe Medical ASA (OSE: OBSERV) today released its presentation of the third quarter 2020, reporting important steps forward in terms of the commercialization and go-to-market strategy for its first product Sippi®. Sippi® is a unique and proprietary solution for digital automated urine monitoring in hospitals. “With Sippi®, Observe Medical contributes to improved clinical results for patients and increased efficiency for the health care system. For us, it is now paramount to roll the Sippi® system out to hospitals, and through the acquisition of Sylak AB,

BERGENBIO ASA: INVITATION TO THIRD QUARTER 2020 RESULTS

Bergen, Norway, 3 November 2020 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, will be announcing its results for the third quarter 2020 on Tuesday 17 November 2020. A webcast presentation by BerGenBio’s senior management team will take place at 10:00 am CET. The live webcast link will be available at www.bergenbio.com in the Investors/Financial Reports section. A recording will be available shortly after the webcast has finished. The third quarter report and presentation will be

SSG: Third quarter 2020 results

(Oslo, 3 November 2020) Self Storage Group ASA (Self Storage Group, OSE:SSG) reported all time high revenues of NOK 75.0 million in the third quarter of 2020, an increase from NOK 71.9 million in the corresponding quarter in 2019, and all time high adjusted EBITDA of NOK 48.0 million (44.1). The company continues to experience limited business impact from the Covid-19 situation, has a solid platform for further profitable growth and targets to open 12 000 -14 000 lettable m2 in 2021.“Self Storage Group delivered another strong quarter with safe operations, profitable growth and several

Aker Carbon Capture third-quarter results 2020

Aker Carbon Capture’s third-quarter highlight was the Norwegian government’s recommendation to realize carbon capture and storage in Norway, marking a breakthrough for the company’s CCS technology.During the third quarter, Aker Carbon Capture was spun off from Aker Solutions and listed on the Merkur Market on the Oslo Stock Exchange, following a successful private placement that raised NOK 500 million.Operationally, the highlight of the quarter came on September 21, when the Norwegian government proposed to launch “Longship”, a complete carbon capture and storage (CCS) project. Aker

Aker Offshore Wind receives funding for Norwegian offshore wind study

Aker Offshore Wind has been awarded a grant from Enova, Norway’s innovation fund for environmentally friendly technologies, for a pre-project that aims to reduce costs and increase maturity in important technical segments of offshore floating wind.The overall objective is to better understand how technical solutions can enable use and development of a Norwegian supply chain and drive down costs over time. “Today's solutions are mature enough to move from the pilot phase to the development of industrial-scale projects. At the same time, the market for floating offshore wind is in an early

Norway Royal Salmon (NRS): Arctic Fish considers listing on Merkur Market

Arctic Fish ehf ("Arctic Fish"), a company owned 50% by Norway Royal Salmon (NRS), has engaged DNB Markets, Pareto Securities and Arion Bank as financial advisers to explore a potential listing on Merkur Market. It is expected that a listing will take place within 1Q 2021. Norway Royal Salmon does not intend to sell any shares in connection with the potential transaction, and a potential outcome of the process is that NRS surpass 50 % ownership in Arctic Fish following the transaction. Arctic Fish is an Icelandic salmon farming company currently operating at five sea sites in three

Norway Royal Salmon (NRS): Q3 20 - Operational EBIT of MNOK 35

Norway Royal Salmon (NRS) reports an operational EBIT of MNOK 35 for the third quarter 2020 and EBIT per kg of NOK 4.21. Corresponding figures for the same quarter last year were MNOK 131 and NOK 19.60. - The market price of salmon has, as normal, been seasonally low in the quarter but is also impacted by the Covid-19 pandemic. In the quarter NRS finished harvest of a generation that has had high production costs. Our margins in this quarter are therefore affected by this. We have had good growth throughout the quarter, and by starting to harvest a new generation we expect lower

Induct - Registration of share capital increase

Reference is made to stock exchange announcement by Induct AS ("Induct" or the "Company") on 2 April 2020 regarding completion of Private Placement of NOK 3 million by NPP Capital AS, a company 100% owned by Alf Martin Johansen, Induct's CEO. The share capital increase pertaining to the Private Placement has now been registered with the Norwegian Register of Business Enterprises. The share capital has been increased with NOK 75,000 through issuance of 750,000 new shares, each with a par value of NOK 0.10. The Company's new share capital is thus NOK 1,266,003 divided by 12,660,030 shares,

FLNG – Changes to the Board composition

November 2, 2020 – Hamilton, Bermuda Flex LNG Ltd (“FLNG” or “the Company”) announces that João Saraiva E Silva has resigned as a Director of the Company. Mr. Saraiva E Silva has served as a Director since September 2019. The Board would like to thank Mr Saraiva E Silva for his contribution and wishes him well in his future pursuits. The Board has commenced a process to identify suitable candidates to fill the vacancy on the board. For further information, please contact: Øystein M Kalleklev, CEO of Flex LNG Management AS Telephone: +47 23 11 40 00 This information is

First sites of Australia’s largest public health system now live with enterprise-wide radiology imaging solution from Sectra

Linköping, Sweden – November 2, 2020 – The sites at the first two local health districts in NSW Health Care are now live with international medical imaging IT and cybersecurity company Sectra’s  (STO: SECT B) radiology imaging solution. The goal is to provide a common platform that enables seamless sharing of medical images and related information across Australia’s most populous state. By facilitating secure, easy and immediate access to medical imaging information, the solution will support NSW Health in providing its patients with timely, high-quality care.“I am

Notice to attend the Extraordinary General Meeting of BioGaia AB (publ)

The shareholders of BioGaia AB (publ) are summoned to an extraordinary general meeting on Wednesday, 25 November 2020. In light of the corona virus, the meeting is held through advance voting pursuant to temporary regulations. Therefore, it will not be possible to attend the meeting in person or by proxy.Right to participateA shareholder who would like to participate in the meeting must (i) be entered in the register of shareholders maintained by Euroclear Sweden AB by Tuesday, 17 November 2020, and (ii) announce their intention to attend the meeting no later than Tuesday, 24 November

Correction: Teleste Corporation - Manager´s Transactions - Tianta Oy

TELESTE CORPORATION MANAGER´S TRANSACTIONS 2.11.2020 AT 20:15 Teleste Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Tianta Oy Position: Closely associated person (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Korpimies, Vesa Position: Member of the Board Issuer: Teleste Oyj LEI: 743700CJRQRU0007GN59 Notification type: INITIAL NOTIFICATION Reference number: 743700CJRQRU0007GN59_20201102161405_2 _________________________________________

DNB Markets: Isofol Medical - Licensing deal for Canada

Isofol Medical today announced it has entered into a licensing agreement with Paladin Labs for the commercialisation of arfolitixorin. Isofol is entitled to up to cSEK205m in upfront and milestone payments, and double-digit royalties. However, like the previous deal, the company is tight-lipped about the deal structure. On our valuation, there should be only potential upside to this deal as it incurs no more costs and leaves the door to a global licensing deal open. We have not updated our out-licensing scenario, hoping for a clearer picture in the Q3 report. We reiterate our fair value of

Immunovia Provides Complementary Details on the IMMray[™] PanCan-d Verification Study

LUND, SWEDEN – Immunovia, a diagnostic company that develops highly accurate blood tests for the early detection of cancer and autoimmune diseases, today announced further details regarding the outcomes of the Verification Study. As previously communicated, the Verification study is the step in the development process where samples are run on the final commercial product with the locked biomarker signature that was derived from the previous Commercial Test Model Study. The Verification Study included samples collected from six sites in Europe and three sites in the US, which mirrors the

Teleste Corporation - Manager´s Transactions

TELESTE OYJ  JOHDON LIIKETOIMET 2.11.2020 KLO 20:15 Teleste Oyj - Johdon liiketoimet ____________________________________________ Ilmoitusvelvollinen Nimi: Tianta Oy Asema: Lähipiiriin kuuluva henkilö (X) Oikeushenkilö (1):Liikkeeseenlaskijassa johtotehtävissä toimiva henkilö Nimi: Korpimies, Vesa Asema: Hallituksen jäsen/varajäsen Liikkeeseenlaskija: Teleste Oyj LEI: 743700CJRQRU0007GN59 Ilmoituksen luonne: ENSIMMÄINEN ILMOITUS Viitenumero: 743700CJRQRU0007GN59_20201102161405_2 ____________________________________________ Liiketoimen päivämäärä:

Third Quarter results 2020

Fornebu, 2[nd] November 2020, Ocean Yield ASA (“Ocean Yield” or the “Company”) announces results for the third quarter 2020.Highlights  · The Board of Directors has declared a dividend of USD 5.15 cents per share. This is an increase of USD 0.15 cents compared to the previous quarter and is the 29th consecutive quarterly dividend declared by the Company.  · EBITDA for Q3 2020 was USD 52.2 million and EBITDA adjusted for finance lease effects was USD 75.8 million. · Net Profit after tax for Q3 2020 was negative USD 104.4 million. This is mainly due to previously announced

Finnish Prime Minister Sanna Marin joins Wärtsilä at Soletair Power for an exclusive tour of a demonstration unit for Power-to-X

Wärtsilä Corporation, News, 2 November 2020 at 6:45 PM EETWärtsilä today welcomed the Finnish Prime Minister Sanna Marin for an exclusive tour of Soletair Power’s facilities in Lappeenranta, Finland, to see Power-to-X technology in action. Power-to-X is a key technology to enable 100% renewable energy. The Power-to-X demonstration unit is a joint development project between Wärtsilä, Soletair Power and Q Power. It converts carbon dioxide (CO₂) captured from the indoor air into synthetic methane by combining hydrogen extracted from water and the carbon dioxide in a biomethanation process.

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 02.11.2020

United Bankers Corporation NOTIFICATION 02.11.2020 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 02.11.2020 Date 02.11.2020Exchange transaction BuyShare class UNIAVAmount 340Average price/share 9.1500 EURHighest price/share 9.1500 EURLowest price/share 9.1500 EURTotal price 3,111.00 EUR The shares held by United Bankers Corporation on 02.11.2020: UNIAV 25,944   On behalf of United Bankers Corporation  Skandinaviska Enskilda Banken AB (Publ) Antti

DIVESTMENT OF TELESTE´S SERVICE BUSINESS IN GERMANY TO CIRCET COMPLETED

TELESTE CORPORATION INVESTOR NEWS   2.11.2020 at 18:15 DIVESTMENT OF TELESTE´S SERVICE BUSINESS IN GERMANY TO CIRCET COMPLETED Teleste Corporation has completed the divestment of the Service business in Germany to Circet Deutschland GmbH according to the release on 2.10.2020. All the conditions for the closing of the deal have been fulfilled and the Federal Cartel Office in Germany has approved the deal. TELESTE CORPORATION Jukka Rinnevaara CEO ADDITIONAL INFORMATION: CEO Jukka Rinnevaara, tel. +358 2 2605 611 DISTRIBUTION:Main media www.teleste.com

There are no items matching the current filter
There are no more items matching the current filter
Back to top